Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover D-30559, Germany.
J Biol Chem. 2010 Apr 23;285(17):13193-200. doi: 10.1074/jbc.M109.080051. Epub 2010 Feb 16.
Protocadherin LKC (PLKC) is a member of the heterogeneous subgroup of protocadherins that was identified and described as a potential tumor-suppressor gene involved in contact inhibition (Okazaki, N., Takahashi, N., Kojima, S., Masuho, Y., and Koga, H. (2002) Carcinogenesis 23, 1139-1148 and Ose, R., Yanagawa, T., Ikeda, S., Ohara, O., and Koga, H. (2009) Mol. Oncol. 3, 54-66). Several aspects of the structure, posttranslational processing, targeting, and function of this new protocadherin are still not known. Here, we demonstrate that the expression of PLKC at the apical membrane domain and its concentration at regions of cell-cell contacts occur concomitantly with significant elevation of PLKC-mRNA levels. Furthermore, it can be found within the adherens junctions, but it does not colocalize with tight junctions proteins ZO-1 and occludin, respectively. Additionally, unlike E-cadherin, PLKC is not redistributed upon Ca(2+) removal. Biosynthetic labeling revealed N- and O-glycosylation as posttranslational modifications as well as a fast transport to the cell surface and a low turnover rate. During differentiation, PLKC associates with detergent-resistant membranes that trigger its redistribution from intracellular membranes to the cell surface. This association occurs concomitant with alterations in the glycosylation pattern. We propose a role for PLKC in the establishment of a proper epithelial cell polarity that requires O-linked glycosylation and association of the protein with detergent-resistant membranes.
原钙黏蛋白 LKC(PLKC)是原钙黏蛋白异质亚群的成员,最初被鉴定为参与接触抑制的潜在肿瘤抑制基因,并进行了描述(Okazaki, N., Takahashi, N., Kojima, S., Masuho, Y., and Koga, H. (2002) Carcinogenesis 23, 1139-1148 和 Ose, R., Yanagawa, T., Ikeda, S., Ohara, O., and Koga, H. (2009) Mol. Oncol. 3, 54-66)。这种新型原钙黏蛋白的结构、翻译后加工、靶向和功能的几个方面仍不清楚。在这里,我们证明 PLKC 在顶膜域的表达及其在细胞-细胞接触区域的浓度与 PLKC-mRNA 水平的显著升高同时发生。此外,它可以在黏着连接中找到,但它不分别与紧密连接蛋白 ZO-1 和 occludin 共定位。此外,与 E-钙黏蛋白不同,PLKC 在 Ca(2+)去除时不会重新分布。生物合成标记显示 N-和 O-糖基化是翻译后修饰,以及快速转运到细胞表面和低周转率。在分化过程中,PLKC 与去污剂抗性膜结合,触发其从细胞内膜重新分布到细胞膜表面。这种结合伴随着糖基化模式的改变。我们提出 PLKC 在建立适当的上皮细胞极性中发挥作用,该作用需要 O-连接糖基化和蛋白质与去污剂抗性膜的结合。